Asthea

The DNA of Dilligence Asthea is a data analytics and machine intelligence project dedicated to revolutionizing the success of investments in new and existing drug innovations. Our solutions enable investors to harness the power of biomedical big data, providing evidence driven insights into the financial risks and opportunities associated with drug therapies. Employing our proprietary data syncretics strategy, Asthea integrates the disconnected worlds of clinical, molecular and financial data, to power a disruptive new approach to investment analytics. Our technology simplifies the interpretation of otherwise complex clinico-molecular datatypes to provide greater insight into the financial implications behind a drugs clinical behaviour. This enables investment firms to embrace the potential of the data driven revolution in medicine, to optimize and de-risk key investment decisions by strategically aligning those decisions with emergent knowledge about a drugs clinical and molecular behavior.